drugset / Trial / NCT01366378

Effect of Cimetidine on the Single-Dose PK of IV- Administered MNTX

NCT01366378

Phase 1 Completed 18 enrolled Bausch Health Americas, Inc.
Non-randomizedSingle-groupOpen-labelTreatment

Summary

This open-label study assesses the single-dose pharmacokinetics of intravenously-administered MNTX in healthy adult male and female subjects in the absence of, and in the presence of, orally-administered cimetidine.

Timeline

Start
2007-01
Primary completion
2007-02
Completion
2007-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Methylnaltrexone Other / unclassified Intravenous

Indications

No indication recorded.